Sponsor:
University of Alabama at Birmingham
Code:
NCT03094026
Conditions
Cognitive Impairment
Hematologic Neoplasms
Hematopoietic Cell Transplant
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Lumosity
Lumosity (waitlist control)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of Alabama at Birmingham on 2024-04-10.